Skip to main content
Clinical Trials/NCT05595733
NCT05595733
Completed
Not Applicable

Can Neurally Adjusted Ventilatory Assist Mode Reduce Mechanical Ventilation Day in Patients With Chronic Obstructive Pulmonary Disease ?

Fu Jen Catholic University Hospital1 site in 1 country50 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
conventional group
Conditions
Obstructive Lung Diseases
Sponsor
Fu Jen Catholic University Hospital
Enrollment
50
Locations
1
Primary Endpoint
ventilator-free days(VFDs)
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

Background: Neurally Adjusted Ventilatory Assist (NAVA) mode is a new mode of ventilator, using electronic potential of diaphragm to adjust tidal volume. At the same time, this mode can trigger and cycle-off inspiratory time by high sensitivity of electronic potential of diaphragm, increase patient-ventilator synchrony, reduce sedative drug, improve oxygenation, shorten mechanical ventilation day and reduce the rate of diaphragm atrophy. It can improve survival rate and hospital day of patients. Both the animal and human experiment have the effect of lung and diaphragm protection Effect: The results of this trial are expected to obtain electronic potential of diaphragm in patients with obstructive pulmonary disease. Reviewing the current literature, few related literatures have such data presentation. This trial hopes to evaluate whether the use of NAVA can reduce mechanical ventilation day by analyzing electronic potential of diaphragm in patients with obstructive pulmonary disease.

Investigators expect that participants with obstructive pulmonary disease using NAVA mode will have significantly less mechanical ventilation day than using conventional mode

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
December 31, 2025
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Obstructive pulmonary diseases include chronic obstructive pulmonary disease (COPD), asthma (Asthma), cystic fibrosis (cystic fibrosis), bronchiectasis (bronchiectasis), bronchiolitis or other diseases that cause airway stenosis, etc.
  • Other patients with obstructive pulmonary disease assessed by the clinical team
  • Consent signed by the principal or legal representative
  • Age \> 20 years old and \< 99 years old

Exclusion Criteria

  • Those who cannot place a nasogastric tube due to medical conditions
  • Pregnant women
  • Those who have received gas cutting
  • Patients with phrenic nerve palsy
  • Neuromuscular disease
  • Intubation due to cardiac arrest

Arms & Interventions

conventional group

Using conventional mode to compare mechanical ventilation day with experimental group

experimental group

Using neurally adjusted ventilatory assist mode to compare mechanical ventilation day with conventional group

Intervention: Ventilator mode

Outcomes

Primary Outcomes

ventilator-free days(VFDs)

Time Frame: up to 28 days

Each day during the measurement period that participants are both alive and free of mechanical ventilation. A participants who is extubated on Day 2 of the study and remains alive and free of the ventilator for the remainder of the 28-day study period.

Study Sites (1)

Loading locations...

Similar Trials